{"id":44044,"date":"2022-05-18T10:01:38","date_gmt":"2022-05-18T08:01:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/"},"modified":"2022-05-18T10:01:38","modified_gmt":"2022-05-18T08:01:38","slug":"patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/","title":{"rendered":"Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Medidata experts to be joined by thought leaders from Moderna, Roche, Bayer, Lundbeck, Parexel, Datavant and UK\u2019s National Institute for Health and Care Research (NIHR)<\/i>\n<\/p>\n<p>LONDON&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&amp;esheet=52722572&amp;newsitemid=20220518005137&amp;lan=en-US&amp;anchor=Medidata&amp;index=1&amp;md5=4ada5513f429cc77e922f1a175f86929\" rel=\"nofollow noopener\" shape=\"rect\">Medidata<\/a>, a Dassault Syst\u00e8mes company, will gather industry experts across drug development, clinical research and operations, data management and digital health to address the industry\u2019s most pressing challenges at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.medidata.com%2Fen%2Fnext-london&amp;esheet=52722572&amp;newsitemid=20220518005137&amp;lan=en-US&amp;anchor=NEXT+London&amp;index=2&amp;md5=39cd62fefc629da979086b8c80d76469\" rel=\"nofollow noopener\" shape=\"rect\">NEXT London<\/a> on May 24, 2022, at Kings Place in North London.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220518005137\/en\/1458766\/5\/Medidata_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220518005137\/en\/1458766\/21\/Medidata_Logo.jpg\"><\/a><\/p>\n<p>\nNEXT London will include keynote presentations, interactive breakout sessions, patient advocate and customer success stories, product demonstrations and networking opportunities. Among the topics covered at the event include:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nHow the industry can deliver on patient centricity with decentralized clinical trials\n<\/li>\n<li>\nPatient engagement in a more controlled COVID-19 world\n<\/li>\n<li>\nHow the industry can empower patients\n<\/li>\n<li>\nData insights to improve study conduct decision-making\n<\/li>\n<li>\nAI-powered evidence generation\n<\/li>\n<li>\nThe power of clinical trial data combined with real world data at the patient level\n<\/li>\n<li>\nHow data and analytics can improve diversity in clinical trials\n<\/li>\n<\/ul>\n<p>\nAttendees will also be hearing from thought leaders from Moderna, Roche, Bayer, Lundbeck, Parexel, Datavant, the UK\u2019s National Institute for Health and Care Research (NIHR, a research partner of the NHS) and patient advocates, among other guest speakers. The full agenda can be found <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.medidata.com%2Fen%2Fnext-london&amp;esheet=52722572&amp;newsitemid=20220518005137&amp;lan=en-US&amp;anchor=here&amp;index=3&amp;md5=6bbdb9495703d1056e5032cc16ade389\" rel=\"nofollow noopener\" shape=\"rect\">here<\/a>.\n<\/p>\n<p>\n\u201c<!-- no quote -->NEXT London is a unique opportunity for industry experts to get together and discuss some of the most challenging issues facing drug development and clinical research today &#8211; including driving more patient centric approaches, making clinical trials more diverse, effectively engaging with regulators and adapting to a more mitigated COVID-19 world,\u201d said Pete Buckman, Senior Vice President of Professional Services and EMEA Site Leader at Medidata. \u201c<!-- no quote -->We look forward to stimulating conversations and meaningful dialogue about how we, as an industry, can continue to improve healthcare and meet the needs of patients around the world.\u201d\n<\/p>\n<p>\nDassault Syst\u00e8mes will also be hosting its <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2F3dslifesciencesforum.com%2F3DSlifesciencesforum&amp;esheet=52722572&amp;newsitemid=20220518005137&amp;lan=en-US&amp;anchor=Life+Sciences+Forum&amp;index=4&amp;md5=dd85c41865bdec736aa36cd31b448f1c\" rel=\"nofollow noopener\" shape=\"rect\">Life Sciences Forum<\/a> at the event to showcase how its solutions enable digital transformation for the life sciences industry to meet today\u2019s ever-evolving business needs. Claire Biot, Vice President, Life Sciences and Healthcare Industry, Dassault Syst\u00e8mes, will be giving the keynote presentation about how modern digital collaboration platforms, which allow for modular manufacturing practices and controlled and streamlined processes, are needed now more than ever to seamlessly and securely exchange data with partners, from tech transfer to plant design, batch release to predictive analytics, and supply chain to supply network.\n<\/p>\n<p>\nMedidata will also be hosting NEXT Basel on June 9, 2022. Further details can be found <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.medidata.com%2Fen%2Fnext-basel&amp;esheet=52722572&amp;newsitemid=20220518005137&amp;lan=en-US&amp;anchor=here&amp;index=5&amp;md5=28f8bb3ef1618ef8c42dbd5d0d43ed2a\" rel=\"nofollow noopener\" shape=\"rect\">here<\/a>.\n<\/p>\n<p>\nAttendance to NEXT London and NEXT Basel is free for customers, partners and qualified members of the life sciences community.\n<\/p>\n<p>\nMedidata is a wholly owned subsidiary of Dassault Syst\u00e8mes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.\n<\/p>\n<p>\n<b>About Medidata<\/b>\n<\/p>\n<p>\nMedidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,900+ customers and partners access the world&#8217;s most trusted platform for clinical development, commercial, and real-world data. Medidata, a Dassault Syst\u00e8mes company (Euronext Paris: FR0014003TT8, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.medidata.com&amp;esheet=52722572&amp;newsitemid=20220518005137&amp;lan=en-US&amp;anchor=www.medidata.com&amp;index=6&amp;md5=4b5cdf05a0c4cfd4d3e538f72c7f80aa\" rel=\"nofollow noopener\" shape=\"rect\">www.medidata.com<\/a> and follow us <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FMedidata&amp;esheet=52722572&amp;newsitemid=20220518005137&amp;lan=en-US&amp;anchor=%40Medidata&amp;index=7&amp;md5=962d0975fdeb03cf3218a33e955197e6\" rel=\"nofollow noopener\" shape=\"rect\">@Medidata<\/a>.\n<\/p>\n<p>\n<b>About Dassault Syst\u00e8mes<\/b>\n<\/p>\n<p>\nDassault Syst\u00e8mes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production. Dassault Syst\u00e8mes brings value to more than 300,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.3ds.com&amp;esheet=52722572&amp;newsitemid=20220518005137&amp;lan=en-US&amp;anchor=www.3ds.com&amp;index=8&amp;md5=9f6618c5e96132b25a6269fb636946aa\" rel=\"nofollow noopener\" shape=\"rect\">www.3ds.com<\/a>.\n<\/p>\n<p>\n3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Syst\u00e8mes, a French \u201csoci\u00e9t\u00e9 europ\u00e9enne\u201d (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and\/or other countries.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nHanna Skeppner<br \/>\n<br \/>Corporate Communications Director, EMEA<br \/>\n<br \/>+44-744-507-2013<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;&#x6f;&#x3a;h&#97;&#110;&#110;&#x61;&#x2e;&#x73;ke&#112;&#112;&#x6e;&#x65;&#x72;&#64;3&#100;&#115;&#x2e;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#104;&#x61;&#110;&#x6e;&#97;&#x2e;&#115;&#x6b;&#101;&#x70;&#112;&#x6e;&#101;&#x72;&#64;&#x33;&#100;&#x73;&#46;&#x63;&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Medidata experts to be joined by thought leaders from Moderna, Roche, Bayer, Lundbeck, Parexel, Datavant and UK\u2019s National Institute for Health and Care Research (NIHR) LONDON&#8211;(BUSINESS WIRE)&#8211;Medidata, a Dassault Syst\u00e8mes company, will gather industry experts across drug development, clinical research and operations, data management and digital health to address the industry\u2019s most pressing challenges at &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44044","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Medidata experts to be joined by thought leaders from Moderna, Roche, Bayer, Lundbeck, Parexel, Datavant and UK\u2019s National Institute for Health and Care Research (NIHR) LONDON&#8211;(BUSINESS WIRE)&#8211;Medidata, a Dassault Syst\u00e8mes company, will gather industry experts across drug development, clinical research and operations, data management and digital health to address the industry\u2019s most pressing challenges at ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-18T08:01:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220518005137\/en\/1458766\/21\/Medidata_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London\",\"datePublished\":\"2022-05-18T08:01:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\\\/\"},\"wordCount\":750,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518005137\\\/en\\\/1458766\\\/21\\\/Medidata_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\\\/\",\"name\":\"Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518005137\\\/en\\\/1458766\\\/21\\\/Medidata_Logo.jpg\",\"datePublished\":\"2022-05-18T08:01:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518005137\\\/en\\\/1458766\\\/21\\\/Medidata_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518005137\\\/en\\\/1458766\\\/21\\\/Medidata_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/","og_locale":"en_US","og_type":"article","og_title":"Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London - Pharma Trend","og_description":"Medidata experts to be joined by thought leaders from Moderna, Roche, Bayer, Lundbeck, Parexel, Datavant and UK\u2019s National Institute for Health and Care Research (NIHR) LONDON&#8211;(BUSINESS WIRE)&#8211;Medidata, a Dassault Syst\u00e8mes company, will gather industry experts across drug development, clinical research and operations, data management and digital health to address the industry\u2019s most pressing challenges at ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-18T08:01:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220518005137\/en\/1458766\/21\/Medidata_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London","datePublished":"2022-05-18T08:01:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/"},"wordCount":750,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220518005137\/en\/1458766\/21\/Medidata_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/","url":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/","name":"Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220518005137\/en\/1458766\/21\/Medidata_Logo.jpg","datePublished":"2022-05-18T08:01:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220518005137\/en\/1458766\/21\/Medidata_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220518005137\/en\/1458766\/21\/Medidata_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/patient-centricity-ai-powered-insights-and-diversity-in-clinical-trials-among-key-topics-at-medidata-next-london\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44044"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44044\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}